Silence Therapeutics plc (SLN)

Silence Therapeutics Revenue

Silence Therapeutics had revenue of $33.86M in the twelve months ending March 31, 2024, with 21.37% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $15.91M with 16.07% year-over-year growth. In the year 2023, Silence Therapeutics had annual revenue of $32.12M with 52.33% growth.

• Revenue (ttm): $33.86M
• Revenue Growth: +21.37%
• P/S Ratio: 28.44
• Revenue / Employee: $310,598
• Employees: 109
• Market Cap: 962.73M USD

Revenue Chart

* The company reports in GBP currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	32.12M	11.03M	52.33%
Dec 31, 2022	21.09M	4.53M	27.38%
Dec 31, 2021	16.55M	9.05M	120.55%
Dec 31, 2020	7.51M	7.18M	2,237.77%
Dec 31, 2019	321.05K	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.